The Direct Medical Cost of Diabetes Mellitus Type 2 Therapy on Inpatients of Hospital X Indonesia

Baroroh, Faridah; Urfiyya, Qarriy Aina

doi:10.1166/asl.2017.10795

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the studies agreed on the conclusions that there is a considerable economic burden related to DM (Ng et al, 2014;Afroz et al, 2018). Previous COI studies related to DM in Indonesia considered only the direct medical cost from the perspective of the healthcare provider in the analysis (Baroroh and Ur iyya, 2017;Anggriani et al, 2019). Our study aimed to estimate COI related T2DM from the perspective of patients and include the direct medical cost, direct non-medical cost, and indirect cost in the analysis.…”

Section: Introductionmentioning

confidence: 81%

Cost of illness of type 2 diabetes mellitus from the patient’s perspective: a study from several primary healthcare centres and a hospital in Yogyakarta, Indonesia

Endarti¹,

Widayanti²,

Rahmawati³

et al. 2020

ijrps

View full text Add to dashboard Cite

Diabetes mellitus is a major health problem that had a consequence of high cost related to treatment and disease impact. This study aimed to estimate the cost of illness related T2DM from the perspective of patients. This study applied a prevalence-based cost of illness study from the perspective of patients. Data of direct medical costs, direct non-medical costs and indirect costs were collected by interviewing patients. The study involved patients covered by the national health insurance scheme as study respondents, which consisted of 96 patients visiting three public primary healthcare centres and 35 patients visiting a private secondary hospital in Yogyakarta Province, Indonesia. From the perspective of patients in Yogyakarta-Indonesia, the total cost of illness of T2DM within three months period was IDR 95,458 (USD 6.58) for patients at PHCs and IDR 340,159 (USD 23.46) for patients at the hospital, which were about 2% to 7% of the minimum wage rate. Indirect cost was the highest contribution of cost of illness (IDR 40,436/USD 2.79) to IDR 398,836/USD 17.63) and followed by direct medical cost (IDR 32,349/USD 2.23 to IDR 44,157/USD 3.05) and direct non-medical cost (IDR 22,673/USD 1.56 to IDR 40,334/USD 2.78). Cost of illness from out of pocket patients in this study was led by visits to other health facilities (the health facilities outside of study site) for obtaining health service related to T2DM disease. This study anticipated that T2DM had a consequence to out of the pocket cost of treatment and further productivity lost of patients and their caregivers.

show abstract

Section: Introductionmentioning

confidence: 81%

Cost of illness of type 2 diabetes mellitus from the patient’s perspective: a study from several primary healthcare centres and a hospital in Yogyakarta, Indonesia

Endarti¹,

Widayanti²,

Rahmawati³

et al. 2020

ijrps

View full text Add to dashboard Cite

show abstract

“…Research by Baroroh et al (2016) showed that the average total cost of outpatient type 2 DM at PKU Muhammadiyah Bantul Hospital Yogyakarta without complications ranged from Rp. 247,753.00 per month.…”

Section: Introductionmentioning

confidence: 99%

“…247,753.00 per month. The average cost of outpatient type 2 DM with complications ranges from Rp 128,143.00 -Rp 1,174,342.00 per month due to the type of therapy and the cost of antidiabetic drugs well as the price of drug complications (Baroroh et al, 2016).…”

Section: Introductionmentioning

confidence: 99%

Cost of Illness Type 2 Diabetes Mellitus Outpatient BPJS on Malang City Health Center

Hidayati

Oktaviana

Pristianty

2022

JFIKI

View full text Add to dashboard Cite

Background: Type 2 diabetes mellitus is a progressive illness that impacts the costs borne by patients. The Cost of Illness method can be used further to analyze the medical expenses for type 2 diabetes mellitus. Objective: Determine the annual total cost of type 2 diabetes mellitus outpatients in Indonesia Health Insurance (BPJS) participants and treated with metformin-glibenclamide. Methods: This study applied the non-probability sampling technique and the purposive sampling method to the cross-sectional approach. The research was conducted in the Mulyorejo Health Care of Malang City, using 58 patients as samples. The research instrument involves a systematic interview that has been tested for its validity. The data were analyzed using Microsoft Excel. Results: The direct medical cost per patient is IDR 173,560.00 – IDR 1,266,240.00. Non-medical direct cost is IDR 0.00 – IDR 240,000,00. The indirect cost is IDR 0.00 – IDR 1,920.000,00. Conclusion: The estimated annual total medical expenses of diabetes mellitus type 2 Indonesia Health Insurance (BPJS) outpatients employing metformin-glibenclamide therapy at Mulyorejo Health Center in Malang is IDR 173,560.00 – IDR 3,426,240.00.

show abstract

The Direct Medical Cost of Diabetes Mellitus Type 2 Therapy on Inpatients of Hospital X Indonesia

Cited by 2 publications

References 0 publications

Cost of illness of type 2 diabetes mellitus from the patient’s perspective: a study from several primary healthcare centres and a hospital in Yogyakarta, Indonesia

Cost of illness of type 2 diabetes mellitus from the patient’s perspective: a study from several primary healthcare centres and a hospital in Yogyakarta, Indonesia

Cost of Illness Type 2 Diabetes Mellitus Outpatient BPJS on Malang City Health Center

Contact Info

Product

Resources

About